| Date Filed | Type | Description |
| 04/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 750,000 shares
@ $0
Granted 750,000 options to buy
@ $0.49, valued at
$367.5k
|
|
| 01/04/2022 |
4
| PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Disposed/sold 300,000 shares
@ $0 |
|
| 12/20/2021 |
4
| PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Bought 135,000 shares
@ $0.375, valued at
$50.6k
|
|
| 07/27/2021 |
4
| PELLETIER SAUNDRA L (Director) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Bought 6,545 shares
@ $3.82, valued at
$25k
|
|
| 06/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2020 |
4
| PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Sold 122,500 shares
@ $3.26, valued at
$399.4k
|
|
| 06/16/2020 |
4
| PELLETIER SAUNDRA L (Director) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Bought 2,500 shares
@ $2, valued at
$5k
Bought 3,000 shares
@ $2.0697, valued at
$6.2k
Granted 4,500 options to buy
@ $2.07, valued at
$9.3k
|
|
| 06/08/2020 |
4
| PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 85,620 shares
@ $3.31, valued at
$283.4k
|
|
| 05/26/2020 |
4
| PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 84,525 shares
@ $4.99, valued at
$421.8k
|
|
| 05/08/2020 |
4
| PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 16,905 shares
@ $5.24, valued at
$88.6k
|
|
| 03/18/2020 |
4
| PELLETIER SAUNDRA L (Director) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Granted 6,000 options to buy
@ $1.12, valued at
$6.7k
|
|
| 03/18/2020 |
3
| PELLETIER SAUNDRA L (Director) has filed a Form 3 on Tracon Pharmaceuticals, Inc. |
| 02/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/04/2019 |
4
| PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Sold 20,000 shares
@ $7.3, valued at
$146k
|
|
| 11/26/2019 |
4
| PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 22,387 shares
@ $6.22, valued at
$139.2k
|
|
| 11/21/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/26/2019 |
4
| PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 4,923 shares
@ $5.13, valued at
$25.3k
|
|
| 06/12/2019 |
4
| PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 35,826 shares
@ $6.36, valued at
$227.9k
|
|
| 04/03/2019 |
4
| PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 3,731 shares
@ $3.55, valued at
$13.2k
|
|
| 12/03/2018 |
4/A
| PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 284,625 options to buy
@ $3.45, valued at
$982k
|
|
| 11/29/2018 |
4
| PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted options to buy
@ $3.45, valued at
$0 |
|
| 08/13/2018 |
4
| PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Bought 10,000 shares
@ $2.11, valued at
$21.1k
|
|
| 07/03/2018 |
4
| PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 825,000 shares
@ $0
Paid exercise price by delivering 493,187 shares
@ $2.46, valued at
$1.2M
|
|
| 03/14/2018 |
4
| PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 825,000 options to buy
@ $7.29, valued at
$6M
|
|
|